All Access Articles |
- Keros Therapeutics Announces $200M Agreement with Takeda | 2025-01-21 | PHARMACEUTICAL
- Keros Therapeutics Halts PAH Trial due to Safety Concerns | 2025-01-15 | PHARMACEUTICAL
- Keros Therapeutics Shows Durable Transfusion Independence in MDS | 2024-12-10 | PHARMACEUTICAL
- Keros Therapeutics secures $200M upfront payment from Takeda | 2024-12-03 | PHARMACEUTICAL
- Keros Therapeutics CEO to Present at Healthcare Conferences | 2024-11-26 | PHARMACEUTICAL
- Keros Therapeutics Appoints Chief Medical Officer | 2024-10-16 | PHARMACEUTICAL